tirzepatide and retatrutide together + Peptide | Research Grade Semaglutide vs. Tirzepatide vs. Retatrutide

Some people also consider the switch after researching the triple-receptor advantage and deciding they want to try a broader approach to metabolic health

For the purposes of your HSA or FSA, the FDA-approved status of the specific formulation is usually less important than the fact that it is a prescription medication

Clinical Trial Results The clinical trial SURMOUNT-5 (NCT05822830) of adults with obesity who did not have type 2 diabetes demonstrated that Zepbound patients had an average weight loss of 50.3 lbs (22.8 kg), which was 20.2% of their body weight, and a 7.2-inch ( 18.4 cm) reduction in waist circumference, at 72 weeks

The most commonly reported adverse effects are gastrointestinal in nature, including nausea, diarrhea, vomiting, and constipation